Pathogenic Mechanisms of DDX41 Mutations in the Development of Myeloid Malignancies

被引：0

作者：

Kon, Ayana ^{[1
]}

Nakagawa, Masahiro Marshall ^{[1
]}

Kataoka, Keisuke ^{[2
,3
]}

Kakiuchi, Nobuyuki ^{[1
,4
]}

Makishima, Hideki ^{[5
]}

Nakayama, Manabu ^{[6
]}

Koseki, Haruhiko ^{[7
]}

Nannya, Yasuhito ^{[1
,8
]}

Ogawa, Seishi ^{[1
,9
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan

[2] Keio Univ, Div Hematol, Dept Med, Sch Med, Tokyo, Japan

[3] Natl Canc Ctr, Div Mol Oncol, Tokyo, Japan

[4] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan

[5] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan

[6] Kazusa DNA Res Inst, Dev Technol Dept, Chromosome Engn Team, Chiba, Japan

[7] RIKEN Ctr Integrat Med Sci, Lab Dev Genet, Yokohama, Kanagawa, Japan

[8] Univ Tokyo, Inst Med Sci, Div Hematopoiet Dis Control, Tokyo, Japan

[9] Karolinska Inst, Dept Med MedH, Ctr Hematol & Regenerat Med, Huddinge, Sweden

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-184519

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] Novel DDX41 variants in Thai patients with myeloid neoplasms
Chantana Polprasert
June Takeda
Pimjai Niparuck
Thanawat Rattanathammethee
Arunrat Pirunsarn
Amornchai Suksusut
Sirorat Kobbuaklee
Kitsada Wudhikarn
Panisinee Lawasut
Sunisa Kongkiatkamon
Suporn Chuncharunee
Kritanan Songserm
Prasit Phowthongkum
Udomsak Bunworasate
Yasuhito Nannya
Kenichi Yoshida
Hideki Makishima
Seishi Ogawa
Ponlapat Rojnuckarin
International Journal of Hematology, 2020, 111 : 241 - 246
[42] GERMLINE DDX41 MUTATIONS : CLINICAL IMPACT & ETHNIC DIVERSITY
Makishima, H.
LEUKEMIA RESEARCH, 2023, 128
[43] Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia
Chlon, Timothy M.
Stepanchick, Emily
Hershberger, Courtney E.
Daniels, Noah J.
Hueneman, Kathleen M.
Davis, Ashley Kuenzi
Choi, Kwangmin
Zheng, Yi
Gurnari, Carmelo
Haferlach, Torsten
Padgett, Richard A.
Maciejewski, Jaroslaw P.
Starczynowski, Daniel T.
CELL STEM CELL, 2021, 28 (11) : 1966 - +
[44] Are DDX41 variants of unknown significance and pathogenic variants created equal?
Xie, Zhuoer
Starczynowski, Daniel T.
HAEMATOLOGICA, 2023, 108 (11) : 2883 - 2885
[45] DDX41: here, there ... and everywhere
Reilly, Christopher R.
Lane, Andrew A.
BLOOD, 2023, 142 (14) : 1177 - 1178
[46] Characteristics and Outcomes of Patients With Acute Myeloid Leukemia and DDX41 Mutation
Bataller, Alex
Loghavi, Sanam
Gerstein, Yoheved
Bazinet, Alexandre
Sasaki, Koji
Chien, Kelly S.
Hammond, Danielle
Montalban-Bravo, Guillermo
Borthakur, Gautam
Short, Nicholas
Issa, Ghayas C.
Kadia, Tapan M.
Daver, Naval
Patel, Keyur P.
Ravandi, Farhad
Fiskus, Warren
Mill, Cristopher P.
Kantarjian, Hagop M.
Bhalla, Kapil
Garcia-Manero, Guillermo
Oran, Betul
DiNardo, Courtney D.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S277 - S277
[47] Genetic Predispositions to Sporadic Myeloid Neoplasms Mediated by DDX41 variants
Takeda, June
Yoshida, Kenichi
Kamatani, Yoichiro
Momozawa, Yukihide
Kubo, Michiaki
Nagasaki, Masao
Chiba, Shigeru
Naoe, Tomoki
Miyazaki, Yasushi
Miyano, Satoru
Sanada, Masashi
Makishima, Hideki
Ogawa, Seishi
CANCER SCIENCE, 2018, 109 : 1104 - 1104
[48] Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms
Talha Badar
Timothy Chlon
Current Hematologic Malignancy Reports, 2022, 17 : 113 - 120
[49] Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms
Badar, Talha
Chlon, Timothy
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (05) : 113 - 120
[50] The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms
Li, Peng
Brown, Sara
Williams, Margaret
White, Thomas
Xie, Wei
Cui, Wei
Peker, Deniz
Lei, Li
Kunder, Christian A.
Wang, Huan-You
Murray, Sarah S.
Vagher, Jennie
Kovacsovics, Tibor
Patel, Jay L.
BLOOD, 2022, 140 (07) : 716 - 755

← 1 2 3 4 5 →